• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 0500316E
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/15/2022
Event Type  malfunction  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
A user facility patient care technician (pct) reported an internal dialyzer blood leak that occurred immediately at the start of a patient¿s hemodialysis (hd) treatment.The blood leak was confirmed to be visually observed in the dialysate compartment of the dialyzer.The machine, a fresenius 2008t machine, alarmed appropriately with a blood leak alarm.A blood leak test strip was not used.No visible damage was observed on the dialyzer.Fresenius bloodlines were also being utilized for the treatment.After the machine alarmed, the treatment was paused.The patient¿s blood was not returned; estimated blood loss (ebl) was less than 300 ml.The pct confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The patient completed treatment after being resetup with new supplies on a different machine.The complaint device was reportedly available to be returned for manufacturer evaluation.
 
Event Description
A user facility patient care technician (pct) reported an internal dialyzer blood leak that occurred immediately at the start of a patient¿s hemodialysis (hd) treatment.The blood leak was confirmed to be visually observed in the dialysate compartment of the dialyzer.The machine, a fresenius 2008t machine, alarmed appropriately with a blood leak alarm.A blood leak test strip was not used.No visible damage was observed on the dialyzer.Fresenius bloodlines were also being utilized for the treatment.After the machine alarmed, the treatment was paused.The patient¿s blood was not returned; estimated blood loss (ebl) was less than 300 ml.The pct confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The patient completed treatment after being resetup with new supplies on a different machine.The complaint device was reportedly available to be returned for manufacturer evaluation.
 
Manufacturer Narrative
Plant investigation: the complaint device was returned to the manufacturer for physical evaluation.The corporate provided blood port and adapter caps were attached to the dialyzer.The fibers were wet with evidence of blood exposure.During gross visual examination, a delamination was observed on the cavity id end of the dialyzer extending from approximately 85° to 290° with the dialysate ports situated at 0°.Further examination of the complaint device did not identify any other damage or irregularities.The sample was not subjected to a laboratory leak test as a delamination is known to affect the integrity of the dialyzer and cause a leak.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was then conducted by the manufacturer.There was one approved temporary deviation notice (dn) reported on the lot which was unrelated to the complaint event.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.The investigation into the complaint was able to confirm the reported event.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas for vision systems and blood leak reduction are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 160NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key15667700
MDR Text Key307005998
Report Number0001713747-2022-00453
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100149
UDI-Public00840861100149
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K162488
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 01/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2022
Device Model Number0500316E
Device Catalogue Number0500316E
Device Lot Number22JU01010
Was Device Available for Evaluation? Device Returned to Manufacturer
Device AgeMO
Initial Date Manufacturer Received 10/17/2022
Initial Date FDA Received10/25/2022
Supplement Dates Manufacturer Received01/13/2023
Supplement Dates FDA Received01/18/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/19/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES
Patient Age75 YR
Patient SexFemale
Patient Weight60 KG
-
-